Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,163.56
(
0.39%
)
US TECH 100
26,498.00
(
0.13%
)
Dow Jones
49,429.75
(
1.16%
)
Brent Oil
109.82
(
-2.28%
)
Bitcoin
76,321.06
(
0.72%
)
News Focus
News Focus
Post# of 64888
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Millenium323

Send PM Follow Ignore
Followers 137
Posts 10066
Boards Moderated 0
Alias Born 04/13/2007

Millenium323

Re: Cache post# 21658

Wednesday, 09/20/2017 9:51:14 AM

Wednesday, September 20, 2017 9:51:14 AM

Post# of 64888
It's becoming obvious the CEO here doesn't know how to get a proper valuation for his stock. How does a pharmaceutical company with a product with an orphan drug designation have a sub $2 million market cap? It should be a minimum of 20x higher than that. That is on the CEO and as a result he is unnecessarily blowing out the share structure.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NPHC News
More NPHC News